Grand River Aseptic Manufacturing opens large-scale injectable fill/finish facility

July 8, 2020
U.S.-based CDMO completes aggressive expansion plan to serve the growing domestic pharmaceutical market.

GRAND RAPIDS, Mich., June 30, 2020 (PRNewswire) — Grand River Aseptic Manufacturing (GRAM), an agile and modern parenteral contract development and manufacturing organization (CDMO), announced it completed its major $60 million expansion project and recently took occupancy.

With the opening of its large-scale fill/finish facility, GRAM more than tripled its existing footprint in Grand Rapids, Michigan, to serve increased client demand in the aseptic fill/finish market. The added capacity, latest technologies and state-of-the-art equipment provide flexible solutions to meet the needs of the most complex sterile injectables.

The new facility located on Butterworth Avenue near downtown Grand Rapids is part of the GRAM campus and is the third fill/finish facility for the company. GRAM now has more than 100,000 square feet dedicated to providing superior quality and service in the marketplace. The Butterworth facility features industry-leading equipment and design, including:

  • Fully integrated, high-speed Bausch+Ströbel filling line
  • SKAN isolators and an IMA lyophilizer auto-loader
  • Grade C cleanroom and formulation suites

"Our customer-minded team and company culture make us unique, and this new facility – with its cutting-edge equipment and technology – further distinguishes GRAM at the top of the industry," said Tom Ross, President and CEO of GRAM. "We look forward to bringing our technical expertise to new clients and continuing to serve our current partners with the highest regard for quality, safety and customer service. I am incredibly proud of how the team applied our culture of innovative thinking and hands-on approach to design this state-of-the-art facility."